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ABSTRACT:
Dengue fever is a viral febrile illness caused by dengue virus and spread by Aedes mosquito worldwide. It usually
manifests as an acute fever associated with body ache, skin rash, and thrombocytopenia. Neurological manifestations
are relatively uncommon but well-known. We report a case of a 25-year-old male patient who presented to our hospital
with acute febrile illness, headache, and vomiting. Extensive laboratory investigations were done and he was diagnosed
with cerebral venous sinus thrombosis. Dengue serology was positive. He was treated with anticoagulation and
hydration with complete recovery. The treatment with anticoagulation is challenging due to accompanying
thrombocytopenia. Only two previous case reports of cerebral venous sinus thrombosis with positive dengue serology
have been reported in the literature.
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A 25-year-old man presented to our hospital with an
eight-day history of high-grade fever, associated with
generalized body ache and vomiting. For the past two
days, he also complained of blurry vision and
headache. Past medical history was unremarkable.
Physical examination revealed a blood pressure of
104/66 mmHg, a pulse of 104 per minute and a
temperature of 102oF. He was awake with intact higher
mental functions. Cranial nerves were intact. He had a
painless maculopapular rash over his left arm. The neck
was supple. His fundus showed bilateral papilledema.
Motor examination revealed a mild right upper limb
weakness with the Medical Research Council (MRC)
grading of 4/5. Motor strength was normal in remaining
limbs. Deep tendon reflexes were normal. Sensory and
cerebellar examination was unremarkable.
Laboratory investigations revealed thrombocytopenia
with a platelet count of 77,000/cmm, a white cell
count of 13,000/cmm with 88.9% neutrophils, and a
hemoglobin of 12 g/dL. Liver enzymes were elevated
with aspartate aminotransferase (AST) of 59 IU/L
(Normal <35 IU/L) and alanine aminotransferase (ALT)
of 222 IU/L (Normal <45 IU/L). Further testing revealed
positive IgM antibodies against the dengue virus.
Malarial parasite was not detected. We did not test for
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chikungunya virus or other arboviruses. Cranial
magnetic resonance imaging (MRI) with venogram was
performed (Figure 1), which revealed filling defects in
the right transverse sinus, right sigmoid sinus, straight
sinus and superior sagittal sinus representing cerebral
venous sinus thrombosis. Electroencephalography
(EEG) showed diffuse slowing suggestive of
encephalopathy. No epileptiform discharges were seen.
An extensive laboratory evaluation for hypercoagulable
states was negative.

Figure 1: Magnetic Resonance Imaging (MRI) of brain
showing hemorrhagic infarct in the right parietal lobe
(yellow arrow in panel A). Magnetic resonance
venogram showing non-visualization of right transverse
sinus (yellow arrow in panel B).
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He was diagnosed with cerebral venous sinus
thrombosis (CVST) secondary to dengue infection. He
was
managed
with
intravenous
hydration,
acetaminophen,
and
anticoagulation
with
subcutaneous enoxaparin 1 mg per kg every 12-hourly,
which was later switched to rivaroxaban 20 mg once
daily. Platelet counts were monitored twice a day. On
the 2nd day of admission, he had one episode of
generalized-onset tonic-clonic seizure. There was no
past history or family history of seizures. He was started
on levetiracetam 500 mg twice daily. On the 4th day of
hospital admission, his blurring vision and headache
improved. His right arm weakness recovered
completely at the time of discharge.

thrombotic complications associated with dengue fever
and previously only two case reports have been
reported in the literature [9,10]. This is the first case from
Pakistan.
Anticoagulation is the main treatment strategy for
CVST, even in hemorrhagic CVST [11]. The decision to
anticoagulate in patients with CVST and positive
dengue serology is challenging due to accompanying
thrombocytopenia. Vasanthi et al. [9] managed their
patient with parenteral fluids replacement only and did
not institute anticoagulation therapy. However, Tilara et
al. [10] administered anticoagulation with subcutaneous
low molecular weight heparin in their case. We initially
managed our patient with therapeutic subcutaneous
enoxaparin followed by oral rivaroxaban, along with
parenteral hydration. We monitored platelet counts
twice daily. Our plan was to continue anticoagulation for
at least three months and transfuse platelets if the
platelet count decreased below 50,000/cmm or the
patient had symptomatic bleeding but none of these
complications occurred. In all the cases of dengue
virus-associated CVST, including our case, the patients
achieved complete neurological recovery.

DISCUSSION:
Dengue viral fever is an acute febrile illness presenting
with fever, headache, joint and muscle pain, and
decreased platelets (thrombocytopenia). It is caused by
a dengue virus (DENV), which is an arbovirus belonging
to the Flaviviridae family. DENV is transmitted by the
bites of female Aedes mosquitoes, Aedes aegypti and
Aedes albopictus. DENV has four serotypes (DENV-1
through DENV-4) [1]. Dengue fever is currently a
pandemic condition. According to the statistics by the
World Health Organization (WHO), approximately 400
million dengue viral infections occur annually. This
number is still under-reported as a large number of
cases are asymptomatic, mildly symptomatic and
self-managed, or misdiagnosed as other febrile
illnesses [2]. The WHO reported more than 47,000
cases of dengue fever in Pakistan in four months from
July to November 2019, with 75 confirmed deaths [3].
Neurological manifestations associated with dengue
viral fever are uncommon but well-known and occur in
about 1% of total cases [4]. The neurological
manifestations
include
meningoencephalitis,
Guillain-Barre syndrome (GBS), acute disseminated
encephalomyelitis (ADEM), transverse myelitis, stroke,
and
cranial
nerve
pathologies,
with
meningoencephalitis being the most common
neurological
manifestation[5,6].
Although
thrombocytopenia is one of the cardinal features of
dengue fever and increases the risk of bleeding, the
cases of large vessel thrombosis have been reported [7].
A number of factors have been suggested with dengue
fever that increase the risk of thrombosis. Dengue virus
enhances thrombomodulin expression by activating
endothelial cells. Activated protein C is downregulated
due to thrombomodulin-thrombin-protein C complex
formation. Low antithrombin III and protein C and S
levels were previously found in severe dengue but in our
case, no similar risk factors were seen [8]. Cerebral
venous sinus thrombosis (CVST) is one of the rare
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CONCLUSION:
Cerebral venous sinus thrombosis is rarely associated
with dengue fever. Anticoagulation and parenteral fluid
replacement are the main treatment regimens for
patients with CVST. The serial platelet counts and the
risk of bleeding should be assessed when treating with
anticoagulation in these patients. The prognosis is
excellent with complete recovery in all three cases
reported to date.
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